TCF4 and glioblastoma: To this end, we treated patient-derived GBM cells with TSA and SAHA for 24 h and confirmed that they were also able to strongly reduce TCF4 protein levels in our patient derived cells (Figure 1A and Supplementary Figure S1A,B).